Oral contraceptives for functional ovarian cysts

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2009, Pages

  Grimes, David A ^a   Jones, LaShawn B ^a   Lopez, Laureen M ^a   Schulz, Kenneth F ^a  

^a FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

Contraceptives, oral, combined *therapeutic use ; Female; Humans; Ovarian cysts *drug therapy ; Randomized controlled trials as topic; Remission, spontaneous

Indexed keywords

CLOMIFENE CITRATE; DESOGESTREL PLUS ETHINYLESTRADIOL; ESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; HUMAN MENOPAUSAL GONADOTROPIN; MESTRANOL PLUS NORETHISTERONE; ORAL CONTRACEPTIVE AGENT;

CLINICAL TRIAL; EMBASE; ENDOMETRIUM TUMOR; HUMAN; MEDLINE; META ANALYSIS; MULTIPLE CYCLE TREATMENT; OVARY CYST; OVARY DISEASE; OVULATION INDUCTION; REVIEW; SYSTEMATIC REVIEW;

EID: 70349099261     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006134.pub3     Document Type: Review

References (42)

1. Bayar Ü, Barut A, AyoÄŸlu F. Diagnosis and management of simple ovarian cysts. International Journal of Gynecology and Obstetrics 2005; 91:187-188 (Pubitemid 41456733)
2. Ben-Ami M, Geslevich Y, Battino S, Matilsky M, Shalev E. Management of functional ovarian cysts after induction of ovulation. A randomized prospective study. Acta Obstetricia Gynecologica Scandinavica 1993;72:396-397 (Pubitemid 23217069)
3. Kilicdag EB, Tarim E, Erkanli S, Aslan E, Asik G, Bagis T. How effective are ultra-low dose contraceptive pills for treatment of benign ovarian cysts?. Fertility & Sterility 2003;80:S218-9.
4. Sanersak S, Wattanakumtornkul S, Korsakul C. Comparison of low-dose monophasic oral contraceptive pills and expectant management in treatment of functional ovarian cysts. Journal of the Medical Association of Thailand 2006;89:741-747 (Pubitemid 44065961)
5. Steinkampf MP, Hammond KR, Blackwell RE. Hormonal treatment of functional ovarian cysts: a randomized, prospective study. Fertility and Sterility 1990;54:775-777
6. Taskin O, Young DC, Mangal R, Aruh I. Prevention and treatment of ovarian cysts with oral contraceptives: a prospective randomized study. Journal of Gynecologic Surgery 1996;12:21-24 (Pubitemid 26124019)
7. Turan C, Zorlu CG, Ugur M, Ozcan T, Kaleli B, Gokmen O. Expectant management of functional ovarian cysts: an alternative to hormonal therapy. International Journal of Gynecology and Obstetrics 1994;47:257-260
8. Biljan MM, Mahutte NG, Dean N, Hemmings R, Bissonnette F, Tan SL. Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues. Journal of Assisted Reproduction and Genetics 1998;15:599-604. (Pubitemid 28565173)
9. Egarter C, Putz M, Strohmer H, Speiser P, Wenzl R, Huber J. Ovarian function during low-dose oral contraceptive use. Contraception 1995; 51:329-333
10. Graf M, Krussel JS, Conrad M, Bielfeld P, Rudolf K. Regression of functional cysts: high dosage ovulation inhibitor and gestagen therapy has no added effect [Zur Ruckbildung funktioneller Zysten: Hochdosierte Ovulationshemmer und Gestagentherapie ohne zusatzlichen Effekt]. Geburtshilfe und Frauenheilkunde 1995;55:387-392
11. Grimes DA, Godwin AJ, Rubin A, Smith JA, Lacarra M. Ovulation and follicular development associated with three low-dose oral contraceptives: a randomized controlled trial. Obstetrics and Gynecology 1994;83:29-34. (Pubitemid 24027376)
12. MacKenna A, Fabres C, Alam V, Morales V. Clinical management of functional ovarian cysts: a prospective and randomized study. Human Reproduction 2000;15:2567-2569 (Pubitemid 32000514)
13. Muzii L, Marana R, Caruana P, Catalano GF, Margutti, Panici PB. Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: a prospective, randomized trial. American Journal of Obstetrics and Gynecology 2000;183:588-592
14. Nezhat F, Nezhat CH, Borhan S, Nezhat CR. Is hormonal suppression efficacious in treating functional ovarian cysts?. Journal of the American Association of Gynecologic Laparoscopists 1994;1:S26.
15. Nezhat CH, Nezhat F, Borhan S, Seidman DS, Nezhat CR. Is hormonal treatment efficacious in the management of ovarian cysts in women with histories of endometriosis?. Human Reproduction 1996; 11:874-877 (Pubitemid 26142191)
16. Peres JAT, Baracat EC, Novo NF, Juliano Y, de Lima GR. Behavior of cystic tumor of the ovary after wait-and-see management and hormonal treatment [Comportamento dos tumores cisticos do ovario apos conduta expectante e tratamento hormonal]. Revista Paulista de Medicina 1991;109:165-173
17. Teichmann AT, Brill K, Albring M, Schnitker J, Wojtynek P, Kustra E. The influence of the dose of ethinylestradiol in oral contraceptives on follicle growth. Gynecological Endocrinology 1995;9:299-305. (Pubitemid 26044689)
18. Young RL, Snabes MC, Frank ML, Reilly M. A randomized, double-blind, placebo-controlled comparison of the impact of low-dose and triphasic oral contraceptives on follicular development. American Journal of Obstetrics and Gynecology 1992;167:678-682
19. Anderson RE, Serafini PC, Paulson RJ, Sauer MV, Marrs RP. Detection and management of pathological, non-palpable, cystic adnexal masses. Human Reproduction 1990;5:279-281
20. Booth M, Beral V, Maconochie N, Carpenter L, Scott C. A case-control study of benign ovarian tumors. Journal of Epidemiology and Community Health 1992;46:528-531
21. Carlsen W, Russell S. Journal retracts Stanford doctors' research articles. Co-author admits using inaccurate data on women's surgeries in report. San Francisco Chronicle 2001 Feb 21; Vol.Sect. A:1.
22. Chiaffarino F, Parazzini F, LaVecchia C, Ricci E, Crosignani PG. Oral contraceptive use and benign gynecologic conditions. Contraception 1998;57:11-18 (Pubitemid 28160429)
23. Christensen J, Boldsen J, Westergaard J. Functional ovarian cysts in premenopausal and gynecologically healthy women. Contraception 2002;66:153-157 (Pubitemid 35217864)
24. Anonymous. Should OCs be prescribed to prevent adnexal masses?. Contraceptive Technology Update 1982;3:116-118
25. Editors. Retraction. Surgical Laparoscopy Endoscopy and Percutaneous Techniques 2001;11:1.
26. The ESHRE Capri Workshop Group. Ovarian and endometrial function during hormonal contraception. Human Reproduction 2001;16:1527-1535
27. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions 5.0.0 [updated Feb 2008]. Available from www.cochrane-handbook. org. The Cochrane Collaboration, 2008.
28. Holt VL, Daling JR, McKnight B, Moore D, Stergachis A, Weiss NS. Functional ovarian cysts in relation to the use of monophasic and triphasic oral contraceptives. Obstetrics and Gynecology 1992;79: 529-533
29. Kozak LJ, Owings MF, Hall MJ. National Hospital Discharge Survey: 2002 annual summary with detailed diagnosis and procedure data. Vital and Health Statistics 2005;13 (158):1-207.
30. Lanes SF, Birmann B, Walker AM, Singer S. Oral contraceptive type and functional ovarian cysts. American Journal of Obstetrics and Gynecology 1992;166:956-961
31. Muram D, Gale CL, Thompson E. Functional ovarian cysts in patients cured of ovarian neoplasms. Obstetrics and Gynecology 1990; 75:680-683 (Pubitemid 20110191)
32. Ory H, Boston Collaborative Drug Surveillance Program. Functional ovarian cysts and oral contraceptives. Negative association confirmed surgically. A cooperative study. Journal of the American Medical Association 1974;228:68-69
33. Parazzini F, Moroni S, Negri E, La Vecchia C, Dal Pino D, Ricci E. Risk factors for functional ovarian cysts. Epidemiology 1996;7: 547-549 (Pubitemid 26277705)
34. Ramcharan S, Pellegrin FA, Ray R, Hsu J-P. Walnut Creek Contraceptive Drug Study. A prospective study of the side effects of oral contraceptives. Vol. 3, Bethesda (MD): National Institutes of Health, 1981.
35. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association 1995;273:408-412
36. Schulz KF, Grimes DA. Generation of allocation sequences in randomised trials: chance, not choice. Lancet 2002;359:515-519
37. Schulz KF, Grimes DA. Allocation concealment in randomised trials: defending against deciphering. Lancet 2002;359:614-618
38. Spanos WJ. Preoperative hormonal therapy of cystic adnexal masses. American Journal of Obstetrics and Gynecology 1973;116:551-556
39. Starks GC. Therapeutic uses of contraceptive steroids. Journal of Family Practice 1984;19:315-321
40. Stein AL, Koonings PP, Schlaerth JB, Grimes DA, d'Ablaing G 3d. Relative frequency of malignant parovarian tumors: should parovarian tumors be aspirated?. Obstetrics and Gynecology 1990;75:1029-1031
41. Vessey M, Metcalfe A, Wells C, McPherson K, Westhoff C, Yeates D. Ovarian neoplasms, functional ovarian cysts, and oral contraceptives. British Medical Journal 1987;294:1518-1520 (Pubitemid 17116355)
42. Westhoff C, Clark CJ. Benign ovarian cysts in England and Wales and in the United States.. British Journal of Obstetrics and Gynaecology 1992;99:329-332